{
}
Pharmacy leaders highlight 2024 as a transformative year, emphasizing the growing focus on reimbursement practices and the role of pharmacy benefit managers (PBMs) in medication costs. The demand for GLP-1 obesity treatments is rising, potentially reshaping chronic disease management and healthcare costs in the U.S. Additionally, the Inflation Reduction Act may influence drug pricing and patient access, warranting close observation.
Alice Chen
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Pharma Leaders Discuss Key Trends Shaping Healthcare in 2024
21:03 05.12.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Economic Indicators
Global Trade Developments
Market Analysis and Predictions
Countries:
Companies:
Currencies:
People: